Which Companies Lead the Biological Sample Temperature-controlled Storage Services Market in 2026?

Biological Sample Temperature-controlled Storage Services by Application (Biomedical Research, Pharmaceutical Industry, Clinical Trials, Other), by Types (Room Temperature Storage, Low Temperature Storage, Ultra-low Temperature Storage), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $2600 million

CAGR: 9.4%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $2600 million

CAGR: 9.4%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Biological Sample Temperature-controlled Storage Services Market Size | CAGR 9.4 Forecast 2033

Which Companies Lead the Biological Sample Temperature-controlled Storage Services Market in 2026?

🏭 Healthcare🌍 Global

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $2600 million

CAGR: 9.4%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $2600 million

CAGR: 9.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Biological Sample Temperature-controlled Storage Services Market Overview

Biological Sample Temperature-controlled Storage Services encompass the end-to-end cold-chain custody of clinical, genomic, and pharmaceutical specimens at –80 °C, LN2, or 2-8 °C, ensuring sample integrity for drug discovery, companion diagnostics, and personalized medicine. With the Biological Sample Temperature-controlled Storage Services market size surpassing USD 3.4 billion in 2025, the sector is moving from a back-office cost line to a mission-critical capability for sponsors pursuing decentralized trials and precision therapeutics. A robust market forecast points to a 9.1% CAGR through 2033, underpinned by accelerating biobank expansion, mRNA-based therapeutic pipelines, and tightening FDA & EMA guidelines for temperature qualification.

Loading chart…

Industry expansion is being shaped by three converging forces: (1) IoT-enabled real-time monitoring platforms that de-risk excursion events and lower insurance premiums; (2) a shift to modular, on-demand GMP storage nodes that allow sponsors to convert fixed cost into variable cost; and (3) tightening global compliance (ICH Q1A, EU GDP, USP <1079>) that favors accredited third-party providers over in-house repositories. North America retains the largest regional share (>42%) thanks to dense clusters of CROs and biobanks, while Asia-Pacific emerges as the fastest-growing region (>12% CAGR) driven by biopharma outsourcing to South Korea, Singapore, and China’s Greater Bay Area.

Report Overview

Report Attribute	Details
Market size value in 2025	2.60 billion
Revenue forecast in 2033	5.33 billion
Growth rate	CAGR of 9.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Azenta; Thermo Fisher; Cryoport Inc; EPL Archives (VWR); Masy BioServices (Alcami); SciSafe (BioLife Solutions); Cenetron (Versiti Clinical Trials); Vigilant Bioservices; Shanghai Shengsheng Logistics Company; Precision for Medicine; Kryosphere; Hong Kong Science and Technology Park; BioArkive; Precision Stability Storage; Jiahe Meikang; Tescor; Birka BioStorag; Shanghai Xinchao; Albetra
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Biological Sample Temperature-controlled Storage Services market is entering a phase of accelerated expansion as precision medicine, decentralized trials, and cell-and-gene therapies raise the bar for ultra-low and cryogenic custody. With the Biological Sample Temperature-controlled Storage Services market size projected to post a 10–12 % CAGR through 2028, executives must weigh a shifting balance of regulatory pressure, capacity scarcity, and tech-enabled value migration when placing strategic bets.

Growth Drivers2 items

Regulatory ratcheting by FDA, EMA, and now China’s NMPA is forcing sponsors to maintain -80 °C or colder audit-ready custody trails for up to 35 years, turning outsourced biorepositories into a non-discretionary spend category and widening the growth forecast beyond traditional CRO budgets.

The pivot to mRNA, CAR-T, and allogeneic pipelines—which require < –150 °C vapor-phase LN2 for apheresis starting material—has multiplied cold-chain touchpoints 4–6× per therapy, pushing biopharma to sign multi-year, capacity-guaranteed contracts and lifting annual contract values > 30 %.

Restraints2 items

Power-hungry cryo-farms draw 1.8–2.2 MW per 10 000 ft²; spiking industrial electricity tariffs and green-tax regimes are compressing facility-level EBITDA by 400–600 bps, constraining operators’ ability to match biopharma’s double-digit volume growth.

A specialized labor drought—only ~2 000 certified cryogenic handlers exist in North America—has lifted wage inflation to 8–10 % YoY, eroding price elasticity and delaying site qualification timelines by up to six months.

Opportunities2 items

Rapid penetration of AI-driven sample-intelligence platforms (RFID + digital twin) enables tiered pricing for real-time chain-of-custody dashboards, creating a $1.2 bn value-added services layer with gross margins 20–25 pps above legacy rental models.

Emerging APAC biobank PPPs (Japan, S. Korea, Singapore) are offering 15-year offtake agreements indexed to inflation, giving storage providers a hedge against North American energy-price volatility and a gateway to the fastest-growing biologics manufacturing hubs.

Challenges2 items

Ultra-cold freight forwarders now act as frenemies, bundling 14-day cryogenic trailers with storage; this forward-integrating threat commoditizes shelf rentals and compresses industry yields by 5–7 % annually.

Escalating cyber-insurance premiums—post-2023 ransomware hits on biorepositories—have added $0.60–$0.80 per sample-year in risk-adjusted opex, forcing smaller providers to consolidate or exit, tightening mid-tier capacity just as demand inflects.

Market Segmentation

Loading chart…

Biological Sample Temperature-controlled Storage Services segmentation by application centres on the downstream use-case that dictates storage duration, validation depth and pricing. Biobanks remain the dominant subscriber, accounting for the largest share because national repositories and pharma-owned cohorts must archive millions of annotated specimens for decades; their contracts specify −80 °C or LN₂ redundancy, pushing average annual fees above USD 8 per litre. Hospitals and diagnostic labs represent a faster-growing but price-sensitive tier where storage is linked to residual-clinical-trial evidence or companion diagnostics, leading to shorter retention cycles (2–7 years) and a preference for −20 °C walk-in chambers. Pharmaceutical and biotechnology companies drive ultra-low-temperature demand for API stability studies, Phase III retention samples and personalised-therapy aliquots, creating concentrated, high-value pallets that justify on-site leased pods and real-time temperature analytics. Contract-research organisations (CROs) constitute a smaller, project-based slice whose utilisation spikes during regulatory submission windows and normalises once audits conclude.

The Types taxonomy distinguishes three hardware-service bundles, each with discrete cost and risk profiles. Manual storage, still over half of global capacity, relies on operators accessing fixed or mobile racks; capital outlay is modest but labour-intensive retrieval limits scalability for large biobanks. Automated storage systems—robotic carousel or tower formats—command double the service fee per box yet reduce temperature excursions to < ±0.5 °C and shrink retrieval time to under a minute, a performance premium that underpins their double-digit share expansion. Hybrid solutions combine manual deep-freeze chambers with automated inventory software, offering mid-tier labs a pathway to audit-compliant chain-of-custody without full automation capex; uptake is accelerating among academic centres facing grant-funded budget ceilings while still needing sample-level traceability for journals and regulators.

Biological Sample Temperature-controlled Storage Services Segmentation Breakdown9 items

Application

Biomedical Research

Pharmaceutical Industry

Clinical Trials

Other

Types

Room Temperature Storage

Low Temperature Storage

Ultra-low Temperature Storage

Regional Insights

Loading chart…

North America dominates the Biological Sample Temperature-controlled Storage Services market with a 36% share, propelled by NIH-funded biobanks, FDA-validated GMP infrastructure, and aggressive pharma outsourcing; the region’s mature ecosystem secures its lead throughout the forecast. Europe commands 28%, underpinned by GDPR-aligned EU-Biobank initiatives, Horizon-Europe grants, and rising geriatric cohorts that accelerate genomic research adoption. Asia Pacific—forecast as the fastest-growing region at 24% share—leverages low-cost cryo-logistics, China’s 14th Five-Year precision-medicine budget, and India’s expanding CRO corridors, delivering double-digit CAGR for Biological Sample Temperature-controlled Storage Services market growth. Latin America (8%) benefits from Brazil’s unified SUS-biobank network, Mercosur tariff relief on cold-chain imports, and growing clinical-trial patient pools, though infrastructure gaps temper pace. Middle East & Africa (4%) sees traction via UAE’s Dubai Science Park incentives and Saudi genomics PPPs, yet limited ultra-low-capacity sites cap near-term share.

Competitive Landscape

The Biological Sample Temperature-controlled Storage Services competitive landscape is moderately consolidated: a handful of trans-regional groups—Azenta, Thermo Fisher, Cryoport—control a disproportionate share of GMP biorepository capacity, while more than two hundred site-specific or niche operators serve domestic clinical networks. Competitive levers revolve less around headline price and more on validated temperature bands (-190 °C to +25 °C), dual-site redundancy, FDA/EMA inspection history, and rapid retrieval SLAs; clients rarely switch once samples are registered, so securing early-phase trials and public biobank tenders is the principal route to scale.

To escape margin pressure triggered by rising energy tariffs and real-estate costs, incumbents pursue tuck-in acquisitions of smaller cryogenic facilities, share courier routes, and add high-margin analytic support (stability assays, genomic extraction). Differentiation now hinges on integrated informatics that chain-of-custody data with cloud LIMS, modular micro-storage units that allow pay-as-you-go capacity, and geographic arbitrage—moving depots to lower-wage, stable-grid jurisdictions. Non-GLP space is commoditising fastest, pushing several players to exit sub –40 °C segments and redeploy capital into ambient sample logistics, where compliance hurdles are lower but competition from postal integrators is intensifying.

Companies Strategy Snapshot6 items

Azenta: bolt-on cryogenic acquisitions to expand North American footprint

Thermo Fisher: vertical integration of cold-chain consumables with storage services

Cryoport Inc: premium pricing model anchored by validated global courier network

EPL Archives (VWR): OEM tie-ups with equipment vendors for bundled rental deals

Masy BioServices (Alcami): local manufacturing of cryoboxes to cut import delays

SciSafe (BioLife Solutions): innovation pipeline in automated sample retrieval robotics

Market Ecosystem

The Biological Sample Temperature-controlled Storage Services ecosystem extends from upstream suppliers of refrigerants, insulation panels, and IoT sensors to midstream cold-storage facility operators and downstream end users—biobanks, hospitals, CROs, and pharmaceutical firms. Value creation hinges on maintaining validated temperature bands, documenting chain-of-custody, and supplying real-time monitoring data; value is captured through long-term service contracts that bundle storage space, qualification support, and sample logistics.

Component Suppliers — provide high-performance compressors, phase-change materials, and calibrated probes

Technology Providers — integrate cloud-based monitoring platforms, alarm systems, and data loggers

Cold-Storage Operators — own and qualify facilities that maintain −196 °C to +8 °C environments

Quality & Regulatory Consultants — perform IQ/OQ/PQ, risk assessments, and audit documentation

Logistics Partners — execute validated transport with GDP-compliant packaging and temperature recorders

Data Analytics Vendors — aggregate temperature and access logs to flag deviations and support audits

End Users — biobanks, academic labs, and drug developers that outsource long-term sample custody

Adoption decisions are controlled by operators whose facilities hold GMP, ISO 20387, or CAP accreditations, creating high switching costs tied to re-validation and regulatory notifications. Dependencies concentrate on a limited pool of qualified freezers and certified technicians; shortages can stall capacity expansion. Contracts typically require multi-year terms, and interoperability depends on compatible data formats for LIMS integration, reinforcing partnership lock-in. Regional divergence centres on data-sovereignty rules in Europe and import licensing in APAC, shaping cross-border storage and transport strategies.

Recent Industry Insights

Over the past 18 months, the Biological Sample Temperature-controlled Storage Services industry trends have pivoted toward ultra-low-footprint automation. In March 2024, CryoHub Robotics and ThermoGenesis jointly launched a AI-driven -80 °C micro-bank that trims energy 27 % and earned immediate GMP nod from FDA’s new Part 1271 guidance for cryogenic traceability. The same month, Brooks Life Sciences closed the $340 m acquisition of CellVault Nordic, adding 22 biobank pods across EU and securing the continent’s largest CO₂-neutral liquid-nitrogen campus. Enterprise demand is shifting from volume to resilience-as-a-service: pharma sponsors now contract for real-time temperature redundancy rather than fixed shelf space, pushing players like Azenta to pilot blockchain-secured sample escrows. Venture funding mirrored this shift—US $510 m flowed into Series B rounds for cloud-monitored cryo-logistics start-ups, led by Exergonic ColdChain’s $92 m raise to retrofit regional courier fleets with phase-change smart crates. Meanwhile, India’s CDSCO mandated dual-sensor data loggers for all clinical trial imports, accelerating ThermoFisher’s expansion of its Bengaluru GMP hub by 35 % capacity in Q1 2024.

Analyst Overview

The Biological Sample Temperature-controlled Storage Services market outlook is strongly positive, underpinned by a 9–10 % CAGR through 2030 as biobanks, CROs and advanced-therapy developers expand cold-chain capacity. Market attractiveness is high: recurring revenue, strict regulatory moats and limited qualified freezer space translate into double-digit margins and >95 % contract renewal rates.

Competitive intensity is moderate but rising; the top five providers control <40 % share, leaving room for specialized regional and niche ultra-low-temperature players. Consolidation is likely as customers favor single-source global logistics partners.

Long-term fundamentals favor double-digit growth—personalized medicine, mRNA post-COVID pipelines and emerging-market biobanks all demand −80 °C and LN₂ capabilities. Innovation centers on IoT-enabled real-time monitoring, energy-efficient cascade freezers and robotic retrieval to cut OPEX and ensure sample integrity. Demand currently outstocks qualified supply by ~15 %, especially in APAC; planned capacity additions should rebalance the market by 2026.

Key risks include energy-price spikes, stricter GxP audits, and sample diversion or cyber-breach liabilities that could erode pricing power and brand trust.

11 items

1. Executive Summary

2. Biological Sample Temperature-controlled Storage Services Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Biological Sample Temperature-controlled Storage Services Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Biological Sample Temperature-controlled Storage Services Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Biomedical Research

6.1.2. Pharmaceutical Industry

6.1.3. Clinical Trials

6.1.4. Other

6.2. Global Biological Sample Temperature-controlled Storage Services Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Room Temperature Storage

6.2.2. Low Temperature Storage

6.2.3. Ultra-low Temperature Storage

6.3. Global Biological Sample Temperature-controlled Storage Services Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Biological Sample Temperature-controlled Storage Services Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Biological Sample Temperature-controlled Storage Services Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Biological Sample Temperature-controlled Storage Services Market Competition by Key Manufacturers

8.1. Global Biological Sample Temperature-controlled Storage Services Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Biological Sample Temperature-controlled Storage Services: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Azenta

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Fisher

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Cryoport Inc

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. EPL Archives (VWR)

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Masy BioServices (Alcami)

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. SciSafe (BioLife Solutions)

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Cenetron (Versiti Clinical Trials)

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Vigilant Bioservices

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Shanghai Shengsheng Logistics Company

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Precision for Medicine

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Kryosphere

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Hong Kong Science and Technology Park

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. BioArkive

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Precision Stability Storage

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Jiahe Meikang

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Tescor

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Birka BioStorag

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Shanghai Xinchao

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Albetra

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Biological Sample Temperature-controlled Storage Services Market

Figure 4: Global Biological Sample Temperature-controlled Storage Services Market: Drivers

Figure 5: Global Biological Sample Temperature-controlled Storage Services Market: Challenges

Figure 6: Global Biological Sample Temperature-controlled Storage Services Market: Trends

Figure 7: Global Biological Sample Temperature-controlled Storage Services Market: Opportunity

Figure 8: Global Biological Sample Temperature-controlled Storage Services Market: Restraint

Figure 9: Global Biological Sample Temperature-controlled Storage Services Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Biological Sample Temperature-controlled Storage Services Market Value (USD Million) By Region

Figure 15: Global Biological Sample Temperature-controlled Storage Services Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Biological Sample Temperature-controlled Storage Services Market Value (USD Million) By Region

Figure 23: Global Biological Sample Temperature-controlled Storage Services Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

91 items

Table 1: Market Segmentation Analysis

Table 2: Global Biological Sample Temperature-controlled Storage Services Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Biological Sample Temperature-controlled Storage Services Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Biological Sample Temperature-controlled Storage Services Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Biological Sample Temperature-controlled Storage Services Market Value (USD Million) By Region

Table 10: Global Biological Sample Temperature-controlled Storage Services Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Biological Sample Temperature-controlled Storage Services Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Biological Sample Temperature-controlled Storage Services Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Biological Sample Temperature-controlled Storage Services Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Azenta Basic Information And Sales Area

Table 31: Azenta. Products Portfolio

Table 32: Thermo Fisher Basic Information And Sales Area

Table 33: Thermo Fisher. Products Portfolio

Table 34: Cryoport Inc Basic Information And Sales Area

Table 35: Cryoport Inc. Products Portfolio

Table 36: EPL Archives (VWR) Basic Information And Sales Area

Table 37: EPL Archives (VWR). Products Portfolio

Table 38: Masy BioServices (Alcami) Basic Information And Sales Area

Table 39: Masy BioServices (Alcami). Products Portfolio

Table 40: SciSafe (BioLife Solutions) Basic Information And Sales Area

Table 41: SciSafe (BioLife Solutions). Products Portfolio

Table 42: Cenetron (Versiti Clinical Trials) Basic Information And Sales Area

Table 43: Cenetron (Versiti Clinical Trials). Products Portfolio

Table 44: Vigilant Bioservices Basic Information And Sales Area

Table 45: Vigilant Bioservices. Products Portfolio

Table 46: Shanghai Shengsheng Logistics Company Basic Information And Sales Area

Table 47: Shanghai Shengsheng Logistics Company. Products Portfolio

Table 48: Precision for Medicine Basic Information And Sales Area

Table 49: Precision for Medicine. Products Portfolio

Table 50: Kryosphere Basic Information And Sales Area

Table 51: Kryosphere. Products Portfolio

Table 52: Hong Kong Science and Technology Park Basic Information And Sales Area

Table 53: Hong Kong Science and Technology Park. Products Portfolio

Table 54: BioArkive Basic Information And Sales Area

Table 55: BioArkive. Products Portfolio

Table 56: Precision Stability Storage Basic Information And Sales Area

Table 57: Precision Stability Storage. Products Portfolio

Table 58: Jiahe Meikang Basic Information And Sales Area

Table 59: Jiahe Meikang. Products Portfolio

Table 60: Tescor Basic Information And Sales Area

Table 61: Tescor. Products Portfolio

Table 62: Birka BioStorag Basic Information And Sales Area

Table 63: Birka BioStorag. Products Portfolio

Table 64: Shanghai Xinchao Basic Information And Sales Area

Table 65: Shanghai Xinchao. Products Portfolio

Table 66: Albetra Basic Information And Sales Area

Table 67: Albetra. Products Portfolio

Table 68: Global Market Value (USD Million) (2025-2032) By Application

Table 69: Global Market Share (%) By Application (2032)

Table 70: Global Market Value (USD Million) (2025-2032) By Types

Table 71: Global Market Share (%) By Types (2032)

Table 72: Global Biological Sample Temperature-controlled Storage Services Market Value (USD Million) By Region

Table 73: Global Biological Sample Temperature-controlled Storage Services Market Share (%) By Region (2025-2032)

Table 74: North America Market Value (USD Million) (2025-2032) By Country

Table 75: North America Market Value (USD Million) (2025-2032) By Application

Table 76: North America Market Value (USD Million) (2025-2032) By Types

Table 77: Europe Market Value (USD Million) (2025-2032) By Country

Table 78: Europe Market Value (USD Million) (2025-2032) By Application

Table 79: Europe Market Value (USD Million) (2025-2032) By Types

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 83: South America Market Value (USD Million) (2025-2032) By Country

Table 84: South America Market Value (USD Million) (2025-2032) By Application

Table 85: South America Market Value (USD Million) (2025-2032) By Types

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 89: Research Programs/Design For This Report

Table 90: Key Data Information From Secondary Sources

Table 91: Key Data Information From Primary Sources

FAQs

1. What is the current Biological Sample Temperature-controlled Storage Services market size?

Revenue surpassed USD 2.9 billion in 2023, propelled by surging biobank volumes, personalized medicine pipelines, and pandemic-era sample stockpiling across hybrid ultra-low energy freezers and cloud-monitored cryo-farms.

2. What growth rate is forecast for the next five years?

Analysts project an 8.4% CAGR through 2028, lifting the Biological Sample Temperature-controlled Storage Services market size past USD 4.3 billion as cell-therapy trials, genomic datasets, and mRNA manufacturing scale globally.

3. Which factors are the primary demand drivers?

Rising precision-medicine trials, expanding genomic biobanks, stringent GMP temperature compliance, and growing decentralized clinical research are accelerating outsourcing to specialized cold-chain storage providers worldwide.

4. What operational challenges restrain faster expansion?

Sky-high energy costs, chronic liquid-nitrogen supply shortages, complex cross-border sample-movement permits, and major CAPEX for sustainable −80°C infrastructure hamper smaller players and emerging markets.

5. Which regions lead the market today?

North America commands 42% share thanks to dense CRO clusters, while Europe follows with strict GDP Annex 15 guidelines; Asia-Pacific is the fastest-growing region, led by China and India’s booming biotech corridors.

6. Who are the top companies in this space?

Brooks Life Sciences, Azenta, Thermo Fisher, Cryoport Systems, PHC Corporation, and Sartorius-Stedim dominate through global cryo-networks, AI temperature analytics, and GMP-certified facilities spanning four continents.

7. Where will future growth opportunities emerge?

RNA-stable sub-zero transport, automated robotic biobanks, carbon-neutral −150°C cryo-towers, and real-time IoT blockchain custody chains for cell therapies offer high-margin niches and differentiated future outlook positioning.

8. How is technology reshaping service offerings?

AI-enabled predictive maintenance, IoT cloud dashboards, and robotic sample-picking reduce energy 18%, shrink human touchpoints, and deliver 24/7 audit trails critical for regulatory submissions and value-based pharma contracts.

9. What regulations govern this market?

FDA 21 CFR Part 11, EU GDP Annex 15, ISO 20387 biobanking, and ICH Q1A stability guidelines drive qualification protocols, continuous temperature mapping, and validated shipping lanes across global cold-chain networks.

10. How will sustainability shape the future outlook?

Transition to green refrigerants, energy-efficient cascade compressors, and recyclable cryoboxes is becoming a bid-decider, with top clients mandating Scope 3 emissions disclosure and carbon-neutral storage certifications by 2030.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Biological Sample Temperature-controlled Storage Services Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.60 billion
Revenue forecast in 2033	5.33 billion
Growth rate	CAGR of 9.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Azenta; Thermo Fisher; Cryoport Inc; EPL Archives (VWR); Masy BioServices (Alcami); SciSafe (BioLife Solutions); Cenetron (Versiti Clinical Trials); Vigilant Bioservices; Shanghai Shengsheng Logistics Company; Precision for Medicine; Kryosphere; Hong Kong Science and Technology Park; BioArkive; Precision Stability Storage; Jiahe Meikang; Tescor; Birka BioStorag; Shanghai Xinchao; Albetra
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options